`
`8:00
`
`9:15
`11:30
`
`AAAAl/ACAAI
`
`Certification/Maintenance of
`Certification Board Review Course
`
`MSW ONlINEA
`"TIE/[EDUCATIONAMALORG[20123 '
`
`Military Allergy Program I!
`0001
`26'I Annual Harold 5. Nelson Allergy/Immunology
`Symposium
`7:20 am to 5:00 [In
`Programmed by m WWW/Inmambaymm orthe
`MMI. Funded howl: an edwaflon amt tom Tm Baspl‘abry.
`Omnnllon Conllr. 523MB. Laval ll
`“'9‘an and ticket remind. No fee. Communal breamst and
`box lunch Included
`Credit: 8.00 CME/ 9.60 CE
`Modelllalr Mark H. Tinker, MD
`Momma mums: AERD and “hill 00mm
`Minn/A. Mlle, MD SAM/II
`Bnflt
`FOIOI ammo I'll! GInICII can Pram
`Llllcll and Brutal Mn: Appllcaflon 11leM In
`magnum and "WWW Prlrnuy Ill'Illl'll Dondonclos
`Thoma/l Helsinr, M) FAMAI
`much I'll! Olnlcll Ola Human
`Brit
`mm IBM! conhr Unfit
`Rellah J.M. Elder, MD BMW
`Mll‘llry WWII emu Lllllrlbry Updatls
`SusanEKnaskxm
`0mm tolllo 811mm: Smallm
`AlrForoo
`WE Scranton, MD
`Army
`MINHBIRNGBMMDPADFAMH
`Navy
`MarkI-l Maker, MD
`4:15
`Buslnou Mootlna and Man! Prunla‘llons
`MmMonolflluuquMHbedlobtmfinwmol
`ulrlndmtlzallonhAElm; mmammtwuormpmmm bloom
`memhlu'olrdlonwrhaflmmdllypuolmhmmba
`coluwomomohmalmmmflnlmunufilyboporhmntldmlflym
`thmmmmmmwm Panama; Dolholnoprlnoua
`ofhlracollrlarllowcwmwy In moulngbrmodlk: PDD;0ulInemewomb
`arm inmumbahhlnlbmtflm Iowqhnolrymalnda.
`
`1:15
`2:15
`2:30
`
`3:00
`
`3:30
`
`3:45
`
`4:00
`
`
`
`2012 ANNUAL MEETING - MARCH 2—6 - FINAL PROGRAM
`at» Allod Ham Pmtsssbml In llokatroqulrod
`63 fee requma V hcludod In momma Annual Morning
`
`AAAAI
`
`mafifggg‘;
`& "“"‘“"""’“-"
`
`23
`
`Page 1 of 108
`
`C SL EXHIBIT 1087
`
`
`
`
`
`Fellows-ln-Tralnlng Program I!
`1011
`
`FIT Symposium
`7:00 am to 2:00 pm
`Peabody, Winderrnere Balloom W, Convellkin Level
`H's-registration and ticket required. No tee. Continental breaktast and
`box Ianh Included.
`Credit: No CME / No CE
`
`7:00
`
`7:30
`
`7:40
`
`8:35
`
`9:35
`
`9:45
`
`From fits to Facilty: Meet Your Putin Breakfast: Nehnoridng
`with PromllentM Protessors and Researchers
`tales from Acalbmla
`Matador: Lemme B. smwartz, AD PhD EMA/ti
`litrodilction to the Program Directors Asembty
`Laurence B. Schwat, MD PhD FMMI
`Tales trom Academia
`HughA. Sampson, MD HAM/II
`Andrea/Saxon, AD FMMI
`Materiel: Martha K. Elias, MD
`Welcome and Opening nemanls
`MatnaK. Elias, AD
`Clmate Change and Its Etiecton Aerobioiogy
`Richard W de, MD FMMI
`Allergic and Non-Alerglc Mechanisms Conirliuting to Upper
`Airway Inflammatbn
`ROMP. Schlelmer, PhD FAMAI
`Welcome item the President
`Dennis K. Ledford, MD 54AM!
`Ditlicilt Clinical Cases in Albrgy: A Master CIInIcIan's Perspective
`Dennis K. Ledi'om, MD HAM/II
`Bleak
`
`10:15
`10:”
`
`11:00
`
`11:3)
`
`12:00
`12:31
`
`1:15
`
`Inmlllomoduiation with Immulotherapy
`Harold 5. Nelson, MD 54AM!
`Accelerated Immilnotherapy Approaches tor Aeroalergens
`mudA. Khan, MD SAM/ll
`Writing Immulioiherapy Prescrqitiolls: A Case—Based Workshop
`Gerald W Volcheck, MD FAAMI
`meh and Nehuorkhg Organizathlns' Amiolllcements
`ABCs ot Coding and Doculriurtation
`GalyN. apes, MD MA!
`Post-Fellowship Reallies
`Eric C. cnenwertn, Do
`Bridgette L Jmes, MD
`Sloan Lee Limb, MD 54AM!
`Whitney Elizabeth Malls, MD 544M!
`Tiishar Shah, MD
`Upon completion ot this session, participants sinuid be able t): Review the underlying
`mechanams driving allergic and non-alerglc Lpper aIway dsease processes; Recomlze
`the ciliicu Indications and aanlrlsiration techniques tor Inmimtherapy; Ewiore novel
`approaches to Imniunotherapy.
`
`Allied Health Course 6» n V
`1101
`Advanced Practice Course
`8:00 am to 4:00 pm
`Peabody, Wildemlero Ball'oom x, Convention Level
`Pro-registration and ticket required. No tee. Lunch hciuded.
`Hogrammedby tneAAMI. Sipportedoyan Iii-kindcaitrtoution tom
`Amine.
`Credit: 5.50 CME / 6.60 CE
`Momlng mdemtol: Gabriel Grit, MPAS PA-c DSMPA
`Ailernwn Maderah‘lr: NInaA. Zimmmnann, MSN MAW-BCAE-c
`Masqueraders oi Asthma: Ctirolilc Cough In Adults
`NInaA Zimmerman, MSN RNANP-BCAE-c
`Masqueraders oi Asthma: Pediatric Case Studbs with PFt
`Examples
`Edivard 0. Garazalia, Ms RPFr
`Bleak
`
`8:15
`
`9:00
`
`9:45
`1 0.00
`
`1 0:45
`
`11:30
`12:10
`
`12:45
`
`1:30
`
`2:1 5
`2:30
`
`Management Isues In the Obese Asthmatk:
`aidsdne w Wayne; W CFNPAE-c
`Alpha-1 Antitrypsli Deficiency
`Jeanette L. Arnold, MSN RN C-FAP
`Lunch Break
`
`Heredtary Angioedema (HAE)
`Gama! 01112, was PA-c 05MB!
`IIIIG: Dttnmt Cases and Clinical Pearls
`DdiraA. Sediaic MSN 0PM"
`rile Allergic Gut
`SaIIyA. Nome, m use cmc
`Bleak
`
`Workshops (Attendees wtl choose one ot the 1000ng sessions.)
`Pro-registration and ticket required. Fee: $20.
`Credh: 1.50 CME/ 1.80 CE
`
`1101A: nuanIopsy
`Peailidy, Bayhill 10, Lobby Level
`Jeanette L. Amold, use RN c-FAP
`Dan J. our, PA-CAE—C
`11015: erlo
`Peabody, Baytlll 20, Lobby Level
`mm o. Oorazalla, us RPFr
`11011:: Atopb omens Patch Tesfllg
`Peabody, Bayhill 21, Lobby Level
`Karol c. Timmons, RNMS am
`11010.- FoodAlergyLab
`Peabody, Bayhill 23 a 24. Lobby Level
`Sally/I. Nome, RN use cmc
`Upon coinpietion otthis session, participants should be able to: Differentiate between
`the patient assessment and differential diagnosis of chrorlc cough at the pediatric vs.
`adult patient populations; Identity various treatments of the dagnosls of chronic culgh
`In pedhtlic and adult populations; Detlne obesity Ii adults and children aid Identity
`education strategies to assist patients It mderstandlng the relationship between obesity
`and mtiirna; Recognize ct'aractenstice of pulmonary manifestations otAIpha-i antitrypein
`deficiency and recdl the mod common exhapuimonary manltestaiiom otAAT deitcienm
`Recognize the stats and symptoms of HAE; beaches curent practice In the diamosls and
`treatment of EoE.
`
`24
`
`AAAAI
`"when Module oi
`Allcrgv Asthma
`
`& Immunuluqy
`
`Page 2 of 108
`
`2012 ANNUAL MEETING . MARCH 2-6 . FINAL PROGRAM
`
`Qt Allied Health Professional a ticket retalired 0 fee required V induded in the \hrtuel Amual Meding
`
`
`
`
`
`Clinical Research Workshop 0»
`
`Course 3 6
`
`1102 Health Literacy: What It Is and How You Measure It
`8:00 to 9:15 am
`Peabody, eaynll21. Lobby Level
`Credit 125 CME / 150 CE
`GardA. Jonas, MAE-c
`mmmmpmpm
`Upon eompietion at 1113 seasbn, periidpanie snolId be able to: Define bealiil literacy and
`Its imporianee In a research eating; Deecllle waysto easily assess heailil literary h a
`mmmfiyenmytedmlquee lo provide pabenteouoeuon by lmorporallop health
`
`1201
`
`0:10
`
`9:5)
`
`Basic Aeroallergen Course
`9:00 am 10 5:00 Pm
`Convention Denier. 83306". I-ml III
`Pre-reglslrailon and ticket required. Fee: $250. Box lunch Included.
`Credit: 7.00 CME/ 8.40 CE
`WMLQWJHDFMMI
`lntroilmlhn to Fmgal Aembbbgy
`W Ell/d!m PhD LEEDAPm]
`an“ m “my
`Estelle Lawm, HID FAMAI
`
`1:3)
`210
`‘
`
`6:15
`
`8:45
`
`0:1 5
`
`10:45
`
`11:15
`
`11:30
`
`11:45
`
`11:40 “some“... won oomple’dm of this session, partlchanis sthd be able to: Identify dIi'iIcuIIies In Ine
`
`PUBLK
`
`EDUCATION MATERIALS
`
`In the Member Resource Center
`
`and receive specialAnnual Meeting discounts
`
`clnieal management 01 IIII'IODIIlllc gasbolntesiinal disease; Describe dimuliiies h the
`clnleal management of Innate immune defects; Explain dilflwiiies h the Interpretation
`01 pulnonary Iunciion abides; means dllIIeuiiles In the cihied managemeni of stony In
`older adulia
`
`Q, Allied Haalih Professional B ticket required 0 fee remind V included in the “final Annual Meeting
`
`AQAAI
`2012 ANNUAL MEETING - MARCH 2-6 - FINAL PROGRAM W WM
`Allergy Asthma
`“‘ Immunu'm"
`
`
`
`25
`
`Page 3 of 108
`
`Hands-0n NEW; 01105“!!! Ir Answer
`10:40
`Chrysafls Program a
`.— 12:00 meh Break
`1111
`2012 Chrysalis Program
`1:11) m“! up a Sammy m“
`8:00 amto12:00 pm
`EstelleLewlIn FliDFAMAI
`Peabody, eaynll 17 a 18, Lobby Level
`'
`Pre-regisb'aiion aid lickei requl'ed. N0 lee.
`Introduction to Pollen Aemblobgy
`Credit No CME/ N0 CE
`:‘zflofimm
`am Welcome and Introduction in All Training
`KimberlyA. Rlsma MDPIID FMMI
`mm W Weber. ”0m’
`3:1!)
`Food Alaryy
`Hands-0n Instruction; nuosiilll 8. Answer
`rl corn atlon of 1113 session,
`rtic
`shruid be able to: Discuss Ine fundamentals
`A' WesleyBWKS, MOMMA!
`mums aid plant reprbduciive mmuow and at sampling; Describe ihe basic
`llnnllnodeflclnmv
`features or spore and pollen morphoioim Identity the mar airborne pollen types and
`Trianas A. Flalshar, MD 54AM!
`i‘unoal spores.
`Eosllophlk: Dlmnhrs
`Amy D. Kllon, w
`9:45 mm
`GmKKhmHBISMMDP/IDW
`Break
`10:15
`10:!) Wemme irorn AMAI Pmsldenl
`DennisKLadIord, MDBMMI
`Atoplc Dermatitis
`Donald KM. Lam MDHIDEMMI
`Acaoamlr: careerPains
`KImberlyA. nlsma Home FAMAI
`lmluslry career Paths
`TTImIZDaan,MD
`Prlvabo Pracllce Career Pains
`Am my [mm m
`
`Course V
`1202 Difficult Cases (Part 1)
`9:003mm122mpm
`oonlrenuon corner. 3310M. Level Ill
`Credit: 2.75 CME/ 3.20 CE
`WMDWYII'SCMMQMDWMI
`Hamod 5 mm m FAMAI
`Eoslmphllc Esophaglllsl EGID
`SeamsnannaAcms. MDPhDBMMI
`W U- m. MD
`Innate Ilnnlunltv
`.brdalflangeJDPanMAl
`53”” 5 W: ”0
`Break
`PFI' Interpralalbn
`Joseph D. Spam. MD
`TMdL. ilostella; MD
`Aibpy In Older Alluis
`PaulaJ.Bwse,MD/54MAI
`VlI'iay Willa, AD
`
`9:00
`
`9:15
`
`10:10
`10:30
`
`11:05
`
`
`
`
`
`Upon completion ofttlis session. participants should be able tm Dbcuss ainent
`knowledge on the comparative emcecy of 800' vs. StJT and ongoing head-b-heed
`comparison trials; Discuss recent data on food alergy Inmunotherapy comparing
`stlilngual aid on! approaches; identify newforms of Immunotherapy under development
`and discuss their potential usefulness and limitations; Discuss new Insights In the
`mechanisms at Inmunotherapy.
`
`Course n 9 V
`
`1205 Allergy Diagnostics and lmmunotherapy: The Nuts, the
`Bolts, the Science and the Art (Part 1)
`9:00 am to 12:00 pm
`Convention Center, 832MB. Level III
`Credit: 1.00 CME/ 1.20 CE
`MommnésiieeES.LaIenasLlnnemann,MDMAAAl
`mums. Tanirersiex MOMMA]
`All You find to Know About Rush and Clister Sctiediles
`mamas madm, MD
`Special sthrations that lieed Dose-Adjustment Dunn: All
`WW cam, MD
`Hands-on Workshops (Allermes Mllrofafebeheeen Mo
`worksia‘ips.)
`Pro-registration and ticket required to attend the hands-on workmops.
`Fee: $25.
`Credit: 2.00 CME I 2.40 CE
`
`9:00
`
`9:30
`
`10.00
`
`12054: Ailerwn ammmom and Take fire Media Fill Tbs!
`Convention Center, smith Level III
`Midimi S Bialss, MD MMAI
`Susan E. Kmlsir}: MA
`Bryan L Martin, DO FMAAI
`Cediia Mlkih MD MPH FAAAAI
`Michael R. Nelson, w PhD 5444A!
`12:58: Preparing an: arm lorAnaplryiaxis and war
`Bneryenchs
`Convention Cenbr, 83200H. Level III
`Preparing Oliice 5qupr am stall
`Data ll Wallace, M) BIAAAI
`cum mam a Code
`NwIIEI Small, MD
`Upon completion dittlis session, participants should be able tm Dbcuss men and clister
`Immunotherapy schedules. premedlcetion and patient selection; Propose Immumtherapy
`schedule adjustments after a gap in admhistratlon. adverse reactions and swttmm
`from one rnanulacturerto another; Discuss what equipment is needed In the allies
`for treatment of an ansphytactic reaction; Demonstrate the aillty b make a sterile
`Immunotherapy vial.
`
`Course
`
`1203 Deeper Insights into the Mechanisms of Asthma and
`Allergic Inflammation
`9:00 am to 12:00 pm
`Conventhn Cutter. 3330“, Level III
`Cl’edlt 2.75 CME I 3.20 CE
`um:3wm R Chalet/a], MD PhD
`Eliseo Keegm, me
`STATS Regulation ofTh2/T reg Balance
`Actual: mgan, me
`Ling DC smsets and Differential Role In T Helpervs.1’ reg
`Responses
`mm Ray, PM
`Novel Endogenous Regulahx of m lrllanlnation: Epilhelal
`Reticuion Nogo-B
`Pauieib Wit/Indieoiia, PM
`Novel Endogenous Regulatns of Th2 Inilamrnatkin: Senaphorins
`ilimshi Iammni, PM
`Break
`
`9:00
`
`9:20
`
`9:40
`
`10:00
`
`10:20
`
`10:40
`
`11:00
`
`11:20
`
`Ciiithase-tho Protalls In the Regulathn of Th2 lnilammatm
`.BckA. Elias, MD
`Regulation of Allergic Airway Disease by I‘ll-Gamma
`Lmn Colin, MD
`Novel Therapy it! Asthnl
`Stephen B. nggett MD
`Question 8. Answer
`11:40
`Upon completion at this session, participants sinuld be able b: Discuss recent
`developments regadhg cell subpopulatlons and lemme factors In aleruc asthna
`complexity; Identity novel endogenous reguabrs otTh2 hilammaticn and their potential
`as novel therapeutic agents; identify how haemad knowledge of novel celubr and
`molecular regulators of allergic dsease enables new therapeutic applcetlons; Define
`novel mechanistic concepts In specific function of dendritlc cells and regulatoryT Cells In
`allergic deease.
`
`Course V
`
`1204
`
`9:00
`
`9:25
`
`9:50
`
`10:15
`
`1&30
`
`10:55
`
`11:20
`
`11:45
`
`NIAID Morning Course: Allergen Immunotherapy:
`Innovative Approaches
`9:00 am to 12:00 pm
`Convention Center. ssiocoeir. Level III
`Credit: 2.75 CME / 3.30 CE
`Maielflor: Marshall Piaut, MD MMAI
`snoutaneous vs. smlhgul Immunotherapy lor Aemallergens
`Stephen R. Durban, MA MD
`Oral Immunotilerapy lor Food Allergens
`A Mosley Boris, MD 5444A!
`htralvmphatic and Epicutaneous Immunotherapy
`ThomasM. idlendig, MD
`Break
`
`Peptide Immmotherapy
`Ma'kLarcne, PM
`New Insights Into the Mechanisms of Immunotherapy
`Karic. Naieau, MDPhDfiAAMI
`Efiects of Immmotherapy on Antigen-Specific T Cels
`William W. Kiwk, PM
`Question 8. Answer
`
`26
`
`AAAAI
`Vin-Hum ALadk 'M L»!
`Allcrgv Asthma
`
`& Immunology
`
`Page 4 of 108
`
`2012 ANNUAL MEETING . MARCH 2-6 . FINAL PROGRAM
`
`Q Allied Health Professional E ticket remired 0 fee required V included in the \firiual Amual Meding
`
`
`
`
`
`Course
`
`1206 Allergens and “Dirt": Molecular Pathways and
`Consequences for the Allergic Epidemic (Part 1)
`9:00 am to 12:00 pm
`Conventiul Center, smell, Level II
`Credit: 2.75 CME/ 3.30 CE
`Modem UIusAlasoM MD 644M!
`em Tile Mollcular Biology of Allergens
`Anna Flames, PhD FAAAAI
`Alergens as Diggers of Pattern Recognllon Receptor Pathways
`MarshaA Wills-Idem, PM
`Particulate Morgans: New Insights Into Allergic Mechanisms
`Soman N. Abraham, PM
`Break
`
`9:25
`
`0:50
`
`10:15
`
`10:5
`
`10:!)
`
`Targeting Alkrgens to FC Remtors: Evaluating the Impact on
`Alerglc Responses
`Judith A. Woafl'olk, Mm PIID FMMI
`DAMPS, PAMPs and More: Iltegrating the Allergic Response
`BarIN. Lambrxht, to PM
`11:20 Moo-um Receptors: Overview and Relevance to Allergic Disease
`stepnanla c. Elsenbam, MD PM
`11:45 mastion & Answer
`Upon completion of tile mien. participants shorid be able to: Explah the averse
`structural and functional properties of alergens and how this relates b allergenlcity;
`Discuss how allergens trigger pattern recognition receptor pathways and hot: tilts Impacts
`allergic Ililarnrnation; Identity the moiectlar basis for how particrlate matter from at
`pollutants prolongs IgE receptor-Initiated standing and potenthtes asthma; Dumbo hon
`pollen-associated Ilpld medhtors activate Innate immune cells and lnodllate dendrttic
`col fillction; Identity how signds from allergen contaminants and carnage-associated
`moiewhr patterns collaborate to Initiate the allergic response; Explain how NOD-Ike
`receptors rrlay shape the allergic response.
`
`Course V
`
`em
`
`9:55
`
`1207 Objective Measure of Lung Function in the Pediatric
`Population
`9:00 am to 12:00 pm
`convention Center, saaoco. Level III
`Credit 3.00 CME/ 3.60 CE
`ModerabnmrwdElgal, MD
`Impulse Oscllornetry nichnlques tor PFts In Very YDII‘Ig Children
`Stanley P. Galalt MD MA!
`Techniques tor Optimlzlrg Splrometry In Preschool Aged Chlk‘lren
`Ham Elgen. MD
`standards and Validation Criteria (ATSIHtS) for Spirometry In
`lbung cIlIdren
`Wayne Joseph Mayan, m
`Question a. Answer
`11:45
`Upon completion of tile session, partidpants stlolld be able to: Explah Impulse
`oscillometry technique for primom'y fulction testing In young children; Dewtbe
`techniques for cptimlzhg spirollletry ll preschool-aged children; ldentilyvald atterla for
`successiul splrcmetry h preached aged ctlld'en.
`
`10:5)
`
`,
`
`Medical Administrator Workshop '0 V
`1211
`Patient Safety: Adverse Events as Guides to Care
`9:00 to 10:15 am
`Peabody, Baytlll 25 a. as, Lobby Level
`Credit: 1.25 CME/ 1.50 CE
`mderabnmtb Bmker
`DonaIdWAamnmn, MDIWIAAI
`Upon completion of tilts session, partichants should be able to: Identity the basic tenets
`and common causes of nledlcel errors It the allergist's office, Antichate and prevent
`medcel errors before [mm "19 patient; Disciose OI'I'DI‘S when they dooccur.
`
`Clinical Research Workshop 0 V
`
`1212
`
`The Anatomy of the Clinical Trial Agreement (Contract)
`and Successful Budget Negotiation
`9:30 to 10:45 am
`Peabody, Bayhll 22, Lobby Level
`Credit:1.25 CME/ 1.50 or:
`Miami: crrelylmeemsrern, m es” cure
`my Weller eswo MA
`Upon completion of title session, partichants should be able to: Identify the components
`of the Clinical Trld Agreement Descrlle the Importance of identifying the Indemrltlcetion
`language It ttle Clinical Trial Agreement; Dismiss principles of budget preparation and
`W800".
`
`Medical Administrator Workshop 0
`
`1301
`
`CPT Coding for the Allergist in 2012
`10:30to 11:45am
`Peabody, eaylrll 20. Lobby level
`Credit:1.25 CME/ 1.50 cs
`mural). MilelvslrtMedAdmln.
`Teresamonlpaon,CPcmsmcoc
`Loon ccinpletion at this session, partlohants shwld be able to: Use the current guidelines
`for CPT and dagnosb coring; Conniywlth Mediocre widelhes.
`
`Clinical Research Workshop 4»
`1302 Data Management: Your Research Data from
`Collection to Paper
`11:00 am to 12:15 pm
`Peabody, Bayhll 23 a. 24, Lobby Level
`Credit:1.25 CME/ 1.50 CE
`Mn arm-Broaden, m
`PahlckJ. Lenehan
`Me L. l/lboert, RNBSN
`Upon completion of this session, partichanis should be able to: Setup, maintain and
`nlodfycese reportfcmlstocoilectstudydatatobe integrated Iltoa dataset; Designs
`bale dafabme to Inclide various types of research data hdudlng case reports and lab
`results; Interpret basic blosiatlstleel results used In presentilg research data.
`
`Clinical Research Workshop ‘0
`1303
`The IRB and Research Ethics
`11:00 am to 12:15 pm
`Peabody, Baytlll 31. Lobby Level
`Credit: 1.25 CME/ 1.50 CE
`DavldBeIde, PhD
`Racys. Estes, PhDRNFAP
`Loon ccinpletion oithls session, partlohants shwld be able to: Describe the historth
`development of, and need tor, formal human subIect protections; Identity common ethical
`Issues associated with human subiect research; Descdbe lite
`roie mil tunction of tile Institutional Review Board.
`
`40 Allied Health Professional
`
`Illa ticket required 0 fee required V included in the \nrlual Annual Meeting
`
`2012 ANNUAL MEETING - MARCH 2-6 - FINAL PROGRAM
`
`AQQAI
`MW Mn... .1
`Allergy Asthma
`
`& Immunology
`
`27
`
`Page 5 of 108
`
`
`
`
`
`Medical Administrator Workshop ® I! 6
`1501
`Roundtable Luncheon: Nuts and Bolts of Practice
`
`Management
`12:00 to 1:15 pm
`PeabodyI Baylrll 32, loony Level
`H's-registration and ticket required. Fee: $40. Box lunch Included.
`Credit: 1.25 CME [1.50 CE
`Mmerd‘ar: John D. Miiausld, Matmrnin.
`Dennis W 800, GPA
`JeaneimBooIar
`Luna 6. Combs, cm
`ThomasllDurkee, CPA
`Teresa nronrpson, 0P0 cmcs ccc
`Upon completion of this session, participants should be able b: Recognize and dlswss the
`operational dialiengas that aidst within a dlnlc arena: Demonstrate amanoad knowiedge
`In operations through peer to peer Interaction will: expem In marketing. human
`resources, social media. air: and legal matters; Recognize operational bed practices that
`are demonstrated h other ethics.
`
`AltTI'ustT'"I Financial Planning In 0
`
`1551
`
`Simple Wealth Planning: You Work Hard tor Your
`Money, Does Your Money Work Hard for You?
`12:30 to 2:00 pm
`Convention Carrier. 3‘. Level III
`Pro-registration and ticket required. Fee: $30. Box lunch Included.
`Credit: No CME / No CE
`Peter M Wiimat CFP
`Mature
`
`Program Directors’ Business Meeting
`2:00 to 4:00pm
`All Program Directors and Co-Dl'ectors are Invited to attend this
`business meeting.
`
`Course V
`
`1601
`
`2:00
`
`2:20
`
`3:00
`
`3:30
`
`4:10
`
`4:40
`
`Technology in the Clinical Practice Made Ridiculously
`Simple
`2:00 to 5:00 pm
`Convention Center. 523055 Level II
`molt 3.00 CME I 3... CE
`Mateia‘aisma: Ddan, MFMMI
`1a; to, MD MYSEMMI
`What Can Technology Do for You Practice?
`TaoLe, MD MHS FMMI
`Ellis and the Meaningful Use of Lle
`Russell B. Lem, MD HAM!
`Practha Managanent Systems and otherwise Automation Tolls
`Linda D. Green, M) FAAMI
`Moblh Devices: IPnones. IPads and Androids, Oh My!
`Mdlnda M. Rdnkopf, MD 54AM!
`Teas for Marketing and Cunnulllcathns
`Vasseiin Dlmoi: MD
`Makirg the Technology Work and Pay Oil
`MindJ. Simian, MD FAMAI
`
`Upon completion olthis session. participants should be able tm Identify the Implications
`of EHR meanhgful use fertile unical practice; Descdbe pradica management systems
`and silica automation technologies mproprhte tor the clinical practice; Explah the role of
`motile technobgies In the practice; List web and social mediatoois ior practice markethg
`and communications; Discuss strategies for successful technology Implementation.
`
`Course V
`
`1602 Difficult Cases (Part 2)
`2:00 to 5:00 pm
`Convention Center, $310ABFE. Level III
`Credit: 2.75 CME / 3.20 CE
`Mama's: David W iiauswiifll, MD HAM!
`Ham 8. Kaikar, MD 54AM]
`Atopy In Pregnancy
`Miami $0312, M7 M5 544M!
`Eugene M Circa, MD
`Sleep Disorders
`El! 0. Meiiza; WHAMI
`Christina E. Ciawlo, m
`Break
`
`2:00
`
`2:35
`
`3:1 0
`3:30
`
`4:05
`
`Mystery Difficult Cases
`Phillip L Liebelman, w BAA/W
`Miami H. Laid, MD
`Reactions to Asp": and NSAIIS
`Dalald D. Sievenmn, MD 64AM!
`my Epshein, MD
`Duestion 3. Answer
`4:40
`Upon completion olthis session. participants should be able 11x Identify aid address
`difficulties h the clrlcal management of stony dulng pregnancy; identify and address
`difficulties It the clnlcal mamgamentofdaep disorders; Identity and address dlfflctlties
`In the clrlcal mamgementoi reactionsto "SAID: Identify and address diagnostic
`dllfiwlties unique to dttliwlt mystery cases
`
`Course D 0 V
`
`1603
`
`Endoscopic Evaluation and Management of Chronic
`Rhinosinusltis (Pre and Post-Surgery) Including
`Cultures
`2:00 to 5:00 pm
`Cmvenlion Center, 8230CD, Level II
`Pro-registration and ticket required. Fee: $25.
`Credit: 3.00 CME I 3.60 CE
`WW8. ”CWMDMMAI
`Anatomy. Endoscopic Videos and Case Management
`Wellington 3. Tlciraur, MD BMMI
`Radology
`S. JamesZInIeich, MD
`Anatomy and Surgery
`Robert 0. Kern, MD
`Upon cornpietion ofthis session. participants should be able to: Describe the anabmy
`oi the slnmes and related strucblres; Identify pathologyon CT scan; Decal Indications
`for surgery and comlcalions of sugary; Perform endoscopy h pre- and post-surgical
`patients; Perform culbnas of middle meatus and/oranuses
`
`2:00
`
`3:00
`
`4:00
`
`28
`
`AAAAI
`\Wnukan ALadk 'M L»!
`Allcrgv Asthma
`
`& Immunology
`
`Page 6 of 108
`
`2012 ANNUAL MEETING . MARCH 2-6 . FINAL PROGRAM
`
`6 Allied Health Professional E ticket required 0 fee required V included in the Virtual Amual Meding
`
`
`
`
`
`men completion of tilts sexton, particbants shotlld be able to: Discuss novel variants cl
`lmmunotherapy. some otthern already at the market and others still under Investigation;
`Disules the useluness ot Imunotherapy in tood allergy and the cunent status of these
`Investigations; Apply ademately the coring, documentation and regulatory guidelines for
`lmmunothelapy.
`
`Course
`
`2:00
`
`1606 Allergens and “Dirt”: Molecular Pathways and
`Consequences for the Allergic Epidemic (Part 2)
`2:00 ti) 5:00 pm
`Convention Center, szaoell, Level II
`Credit: 2.75 CME/ 3.30 CE
`Madelatbl: Mathews Felzanawsid, PhD
`studying the Efldemldogy ot Asihna: Multiple Factors and
`Contenders
`WK. Idlllrana Hadley, MD PhD 54AM!
`Geogmphlc Detennlnants ot the Asthma Eplchmlc
`ThomasAE. Halts-Mile, M) PhDFAMAI
`Gene-Environment Interactions and Asthma: Update
`Femando D. Martinez, m
`Break
`
`2:5
`
`2:50
`
`3:15
`
`3:55
`
`3:30
`
`The Itlsk ot Abpy and Microbial Exposure: Where Do We stand?
`Erika Von Mutius, MD MSc
`Asthma and the Urban Environmmt: Lessons from the Inn City
`Asthma Consortium
`me 3. Wild, MD PhD 54AM]
`4m Lesons lrorn the URECA Birth Cdlat study: Albrgens, Mbrobes
`and More
`James E. Gem, MDFMMI
`Question 8. Answer
`4:45
`Upon completion otthls session, pertichants shotlld be able to: Emlaln him to perform
`well designed studies on the epidemiology ot asthma; Describe cunent knowtedge ot
`oene-envtonrnent Interactions that oonhtbute to asthma; Apply current knowledge
`of mlaoblal elgmure as a detennlnant ot atopy, 0m” how the urban envtonment
`Impacts mthma; Explain how a birth cohort shldy aims to exanlne the multi-lacbrtal
`origins ol asthma; Identify the geographic detennhants of asthma.
`
`Course
`
`1604
`
`me
`
`2:25
`
`2:50
`
`3:1 5
`
`NIAID Afternoon Course: Links Between Innate and
`Adaptive Immunity
`2:00 to 5:00 pin
`Conventiul Center, sazoco, Level III
`Credit: 2.75 CME/ 3.30 CE
`Modem Gang Dali], MD Pm
`The Role or Microbial Flora In Immune Responses
`Ronald Coiirnan, MD
`TSLP and negation of Allergic InthmatIon
`stove Ziegla, PhD
`Llnldng Innate and Adaptive Responses to Vaccltes
`Bail Pulendl‘an, PilD
`Break
`
`3:30
`
`3:55
`
`4:20
`
`Innate and Adaptive Immune Responses II Chronic Uppa Alway
`Inflammation
`Robert}? Sdllelmer, PhD FMMI
`Innate and Adaptive Imnlunly In Alergl: Respiratory
`Inflammation
`Bari”. Lambrwflt, in PM
`Innate and Adaptive Imnlunly In the Gashuntesthlal Tract
`Gay 5. lit/tillage, PhD
`Ollestton a. Answer
`4:45
`Upon completion or tile session, pertidpants shelld be able to: Discuss current
`knowledge of the Inmte and adaptive Inmune responses; Describe the role ofthe
`mlcroblome on tile Innate and adultive Immune responses; Discuss new lmlgtltstorthe
`role of the Inmte inmune response on the development at allergic disorders.
`
`Course II! 0 V
`
`1605 Allergy Diagnostics and Immunotherapy: The Nuts, the
`Bolts, the Science and the Art (Part 2)
`2:00 to 5:00 pin
`Convention Center, 8321MB. Level III
`Credit: 1.00 CME/ 1.20 CE
`Moderators Linda Cox, MD FAMAI
`Ira Flrlegald, MD h'MMI
`2m Future of Inhalant Allergen Inmlllotherapy
`Thomas 5. Basis MD FAMAI
`Use ol Immmotherapy In the matrnent ot Food Allergy
`Hugh/I. Sanwson, M) FMMI
`am Hands-0n Workshops (Aibndees wilmcvb bellman two
`workshops.)
`Pre-registration and ticket requl'ed. Fee: $25.
`Credit 2.00 CMEI 2.40 CE
`
`2:30
`
`1cm: Codrlg, Docunenbdon all! ABCs orRegulahry
`Gumtree
`Convention Center, 8320EF, Level III
`Donald W Aa'onson, MD FMMI
`DavidA. Brown, MD
`Gay M. Cross, MD 544M!
`1MB: Allergy Sldn Tbstllg: Desks and Beyom
`Conventim Center, smell. Level III
`Skin Teslhg In Helical Praedce
`John Oppenheimer, MD new
`Skin lasing tor ankle! Trials
`Peters. creams, no my
`ArtandScienceorPercmneoosmnreslnp
`stenKtiDrebrrg, WWW!
`
`49 Allied Heeith Professional an ticket required 0 fee required V included in the tunnel Annual Meeting
`
`2012 ANNUAL MEETING - MARCH 2-6 - FINAL PROGRAM
`
`Page 7 of 108
`
`AQQAI
`-\thlI4.A’I Mad-:l'n ul
`Allergy Asthma
`
`a lmmunulugv 29
`
`
`
`
`
`COUI'SO
`
`1607
`
`2:00
`
`2:20
`
`2:40
`
`3:00
`
`3:20
`
`NIEHS Course: Epidemiologic Methods in Asthma and
`Allergy Research
`2:00 to 5:00 pm
`Conventbn Guitar. seetAe, Level III
`G’edlt: 2.75 (ME I 3.30 CE
`Mmera‘or: Darylc. Zerorrl, MD
`Overview 01 Epidemiological Methods in Asthma and Allergy
`Research
`Christine DoleJohnson, mom: swell
`Iitrudwtion to Genetic Epidemllbgy
`Kathleen c. Barnes, PhD FAMAI
`Respl'atory Disease nuesbonilns
`George I? 0’ Donner; MD
`Outdoor Eitposuie Assessment
`Jalme Halt. 3:0
`Break
`
`3:35
`
`3:55
`
`4:15
`
`litiotl' Expomre Assessment
`innylc. Zeldln, MD
`Delinlng Allergy and Asthma outcomes Ii Epliemleloglc strides
`Dennis R. Dwnliy, MD 64AM]
`Publcty Available Databases oi Asthma and Allergy Research
`David M. Maurine, MD
`lanai Discussion
`4:35
`Upon completion or this session, participants stnuld be able I): Apply epldemlologlc
`methods to astima and alergy research; Identity exposure aid outcome measures.
`
`Course in 9 V
`
`1608
`
`2:00
`
`2:30
`
`3:05
`3:15
`
`Interpretation oi Pulmonary Function Tests
`2:00 to 5:00 pm
`convention center. moo, Level III
`Pro-registration and ticket required. Fee: $25.
`Credit: 3.00 CME / 3.00 CE
`Maierdon MarkF. Salds, MDW
`Ling Pathophysiology and the PFT
`MattF. Sands, M) RAM]
`Filling It All Together. From Physiology til interpretation
`Donald R Tashkln, MD
`Question 8. Arswer
`Hands-0n Sesslln
`Donald w cadaver: MD 5444A!
`Maedldl c. MoGorrrrmk, MD
`leardo Mina, MD PhD FMMI
`Ma'kE Sands, to BMW
`Donald}? iasnkln, MD
`John M. Wdla‘, MD 54AM]
`Upon completion 01 this session, participants should be able b: Dhcuss basic lung
`physiology and patttophyslology and mechanics relating to restrictive and obstructive
`disease: Discuss AIS/Ens criteria tor diamosls of simple and complex restrictive and
`obstructive detects; Discuss criteria for tedinlcely acceptable Pm: and corrective
`measures tor technch problems; Define ling volumes. capacities and the ettectot
`
`Motive and obstructive dl Pin-1'» ttieretpon; Identity flow volume loop pattems
`In restrictive/obstructivelmlxed and variable obwucttve conditions; Independently
`Interpret splrometry aid complete PFTs, demonstrating skill In flow-volume loop pattern
`recomliion.
`
`Course
`
`1609
`
`2:00
`
`Finding a Job and Getting Started in Practice
`2:00 to 5:00 pm
`cmvention Center, 823MB, level II
`Credit: 3.00 CME/ 3.60 CE
`MomtrtBrialA. Shaft MDFMAAI
`Overview 8. Intruductllns
`
`2:10
`
`2:45
`
`3:00
`
`3:45
`
`Flndlig a Job and Negotiating the Agreement
`Welly soong, MD
`Getting Licensed and Transltlonlig Into Practice
`Bria: A szt, MD 54AM!
`Badc Operations 01 a Practice
`David L Patterson, MD FMMI
`Practitn finances 101
`Marshall B Groddsky, MD FAAMI
`Marketlig Your Practice
`Shirley M. Hrreman, MD MBA 54AM!
`Upon cotnpietion otttlls session. participants should be able to: Explain bowto Identity
`and loin the right practice opporhlllty; Discuss the hlldamentals oi oitlce malagemeni;
`Identity strategies tor marketing a practice and building a patient base.
`
`4:20
`
`Course V
`
`2:00
`
`1610 Upper Airway Disease and Comorhidities
`2:00 to 5:00 pm
`cmvention Center, $33000, Level III
`Credit: 2.75 CME / 3.30 CE
`Mamie“: wmnlo Eblsawa MD PhD EMMI
`Anne-M6194 Iran], AD FMMI
`Ruby U. Pawarlkz, MD Pl‘iD 54AM!
`Adam S. Putamal, MD FMMI
`Cunabltlths oi Alergl: Ithlnlts: Asthma, RhIiosInusltis and
`Mills
`Ruby U. Pawalkan MDPIIDW
`Chronl: Cough In Upper Airway Disease
`Nasal A Rosario, MD PhD FMAAI
`llral Inieciions In Pediatric Umer Airway Disease
`Oma' relays: MD
`Break
`
`2:25
`
`2:50
`
`3:15
`
`3:30
`
`3:55
`
`4:20
`
`Upper AIway Disease and Sleep Disorders
`RlchId J. SMD, W
`Eosinophilc Eophagltis and Pollnosls
`Cam Ilanl, MD 5444A!
`Upper Airway Disease and Oral Allergy Syndrome
`MonbsarratFanandez-Rlvas, MD mo
`Question 8: Answer
`4:45
`Upon cornpletlon otttlls session. participants should be able ttx Dbcussthe latest
`evidence on co-morbldlties oi allergic rtirltis, impecton qualityot lite aid wont
`productivity; Identity the 00qu symptomatnlogy, mechanisms and lrrpact of clients
`cough h upper airway disease; Describe the role 01 viral Infections in exacerbation at
`upper airway disease as they pedal: to both the pathogenesis and treatment Eloildn
`the mmorbldltyoi sleep disorders with upper airway dbease Incidence, consetmences
`and morbidity. Descttbe the Inter-relation between pollnosis and eoslnophllc eseptlagttis
`and underlying mechanisms; Discuss the symptom protle, meohalisrns and spedtics 0t
`treatment of oral allergy syndrome.
`
`30
`
`AAAAI
`Vin-linen ALadk 'M L»!
`Allcrgv Asthma
`
`& Immunology
`
`Page 8 of 108
`
`2012 ANNUAL MEETING . MARCH 2-6 . FINAL PROGRAM
`
`0 Allied Health Professional E ticket remind 0 fee required V included in the \firtual Amual Meding
`
`
`
`
`
`Course V
`
`Course
`
`1611
`
`me
`
`2:50
`
`Refresher in Basic Immunology to Support a Cutting-
`Edge Allergy/Immunology Practice
`2:00 to 5:00 pin
`Conventim Center, 831000611, Level III
`Credit: 2.75 CME/ 3.30 CE
`Modammnmma Chaplin, MD PhDFMMl
`Mechanisms of Adaptive Immunly
`E. Richard atone), MD FAAAAI
`Subsets, Subsets. Subsets: Important Immune Gel Populations In
`the News and Our uterattle
`KathIeenE. Sullivan, MDPhDFAAMI
`Break
`
`3:15
`3:30
`
`3:55
`
`4:20
`
`When Imrnurltty Becomes confused: Immunological
`Understandltg horn Autolnmunlty and Irllamrnatory Disease
`John S Sundy MD PhD 54AM!
`When Imrnurltty Breaks: Imrntlrrloglcal Understanding rnln
`Primary Immurodetidency
`FranclscoA. Balltta, MD PhD 544M!
`Recent Basic Immunobgical Discoveries tirat are Ukely to Impact
`the Practice at Allergy and lmmrlroiogy
`Troy R. Itryelson, MD PhD
`Dlrestkln 3. Answer
`4:45
`Upon completion of iris mien. pertidpants ahotld be able to: Explain how the different
`components rt the Immune system are coonlnated witiin the body to generate an
`Inmune response; Dlawss recent developments regadhg cell subpopulaiions and
`InInune tactcrs required tor physiologic and aberrant (alergic or antiseit) InInune
`responses; identity hm haeased kneMedge ordgnalhg pathways ermtes new
`therapeutic applications in diergy/Irrlnunoiogy.
`
`Course
`
`1612
`
`Clinical Management of Allergic Skin Diseases
`2:00 to 5:00 pin
`Convention Center, ssaoui. Level III
`Credit: 2.75 CME/ 3.30 CE
`Moderators Luz S. Fonwlw, MD MA!
`Sam/tram: sanl, mom
`2m Diagnostic Testhrg In Atbpic Dermatitis
`Andres lMolimDerg, MDEMMI
`Therapy ct Aboplc Dermatitis
`Lynda G. 5mm MD RAM!
`Break
`
`2:30
`
`and
`
`4:15
`
`3:1 5
`
`3:45
`
`Management or UrticarlaIAngleedema
`Jonathan/t Bemsbln, MD MMAI
`Diagnostic resthrg In ultaneous Drug Reactions
`DavidA. Iaian, MD EMMI
`Management of cutaneous Drug Reactions
`Nell Slear, MD
`Question 3. Answer
`4:45
`Upon completion or the session, partidpanta aholld be able to: Select appropriate
`diamostic procemrea h atoplc dermatitis patients aid develop a management strategy.
`Perform atate-ot-tile-art diagnowcs and treatment or urticaria and angloedema according
`ID the new practice puaneters; Select appropriate diagmstic BMW” In 0180110813
`and "$11806th dl‘lio allergies
`
`2:1!)
`
`2:20
`
`2:40
`
`1613 Biomarkers in Airway Diseases
`2:00 to 5:00 pm
`Converlkln center. ssaosr, Levd III
`Credit: 2.75 CME/ 3.